Prefer a chat interface with context about you and your work?
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials
Estimations of the treatment effect on overall survival (OS) may be influenced by post-progression therapies (PPTs). It is unclear how often OS analyses account for PPT effects. The purpose of this cross-sectional analysis was to determine the prevalence of OS analyses accounting for PPT effects in phase III oncology trials. …